mevalonic acid has been researched along with Coronary Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blankier, S; Ito, S; McCrindle, BW; Yeung, RS | 1 |
| Hu, WL; Li, JJ; Qian, SB; Qiao, SB | 1 |
| Monger, EA; Nestel, PJ | 1 |
| Jakober, B; Klass, C; Knisel, W; Naoumova, RP; Pfohl, M; Risler, T; Thompson, GR | 1 |
| Betteridge, L; Chan, P; Clunn, G; Gallagher, K; Hughes, A; Munro, E; Patel, M; Schachter, M; Sever, P; Wolfe, J | 1 |
| Lewis, LS | 1 |
| Firth, JC; Marais, AD; Mountney, J; Naoumova, RP; Rendell, NB; Taylor, GW; Thompson, GR | 1 |
| De Caterina, R; Lenzi, S | 1 |
| Corsini, A | 1 |
| Brown, MS; Goldstein, JL | 1 |
| Isselbacher, KJ; McIntyre, N | 1 |
| Bencze, WL; DeStevens, G; Hess, R | 1 |
| Miettinen, TA | 1 |
5 review(s) available for mevalonic acid and Coronary Disease
| Article | Year |
|---|---|
[Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diet; Endothelium, Vascular; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Lovastatin; Male; Mevalonic Acid; Middle Aged; Physical Exertion; Primary Prevention; Simvastatin; Time Factors | 1998 |
Fluvastatin: effects beyond cholesterol lowering.
Topics: Animals; Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Endothelium, Vascular; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Mevalonic Acid; Muscle, Smooth, Vascular; Platelet Activation | 2000 |
Hyperlipidemia in coronary heart disease: a biochemical genetic approach.
Topics: Alcohol Oxidoreductases; Cells, Cultured; Cholesterol; Coronary Disease; Enzyme Inhibitors; Fibroblasts; Glutarates; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Mevalonic Acid; Protein Binding; Thyroid Function Tests; Time Factors | 1975 |
Role of the small intestine in cholesterol metabolism.
Topics: Alcohol Oxidoreductases; Animals; Bile Acids and Salts; Biological Transport; Cholesterol; Cholesterol, Dietary; Chylomicrons; Coronary Disease; Dietary Fats; Esters; Feces; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Lipoproteins, VLDL; Liver; Lymph; Mevalonic Acid; Sterols; Structure-Activity Relationship | 1973 |
Hypolipidemic agents.
Topics: Acetates; Adult; Animals; Azoles; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet; Dogs; Esters; Estrogens; Female; Haplorhini; Heart Diseases; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Mevalonic Acid; Mice; Middle Aged; Nicotinic Acids; Oxazoles; Prostaglandins; Pyrazoles; Pyridines; Rats; Steroids; Thyroxine | 1969 |
1 trial(s) available for mevalonic acid and Coronary Disease
| Article | Year |
|---|---|
Acute and chronic effects on cholesterol biosynthesis of LDL-apheresis with or without concomitant HMG-CoA reductase inhibitor therapy.
Topics: Adult; Blood Component Removal; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Mevalonic Acid; Middle Aged | 1994 |
7 other study(ies) available for mevalonic acid and Coronary Disease
| Article | Year |
|---|---|
The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.
Topics: Animals; Antigens, Bacterial; Arteritis; Atorvastatin; Cell Wall; Coronary Aneurysm; Coronary Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Lacticaseibacillus casei; Lymphocyte Activation; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mevalonic Acid; Mice; Mice, Inbred C57BL; Mucocutaneous Lymph Node Syndrome; Pyrroles; Specific Pathogen-Free Organisms; Superantigens; Tumor Necrosis Factor-alpha | 2011 |
Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin.
Topics: Animals; Atherosclerosis; C-Reactive Protein; Cells, Cultured; Coronary Disease; Diterpenes; Dose-Response Relationship, Drug; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mevalonic Acid; Monocytes; Polyisoprenyl Phosphates; Resistin; Risk Factors; Rodentia; Signal Transduction; Simvastatin; Time Factors; Up-Regulation | 2007 |
Turnover of plasma esterified cholesterol in normocholesterolemic and hypercholesterolemic subjects and its relation to body build.
Topics: Adult; Body Surface Area; Cholesterol; Coronary Disease; Humans; Hypercholesterolemia; Injections, Intravenous; Male; Mevalonic Acid; Middle Aged; Obesity; Tritium | 1967 |
Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis.
Topics: Adenine; Cell Division; Cells, Cultured; Cholesterol; Coronary Disease; Farnesol; Humans; Isopentenyladenosine; L-Lactate Dehydrogenase; Lovastatin; Mevalonic Acid; Muscle, Smooth, Vascular; Saphenous Vein | 1994 |
Statins, cholesterol, and mevalonate pathways?
Topics: Anticholesteremic Agents; Cholesterol; Coronary Disease; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Mevalonic Acid; Simvastatin | 1996 |
Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Coronary Disease; Enzyme Inhibitors; Female; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Lipoproteins, LDL; Lovastatin; Male; Mevalonic Acid; Middle Aged; Pravastatin; Pyrroles; Simvastatin | 1996 |
Effect of nicotinic acid on catabolism and synthesis of cholesterol in man.
Topics: Adult; Bile Acids and Salts; Cholesterol; Coronary Disease; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Mevalonic Acid; Middle Aged; Myocardial Infarction; Nicotinic Acids; Steroids; Triglycerides; Tritium | 1968 |